Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer

In non-small cell lung cancer (NSCLC), two key genetic alterations, epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements, are commonly believed to be mutually exclusive. Studies have reported that concurrent EGFR/ALK co-mutation in non-small cell lung...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Haoyue Hu, Songtao Tan, Meng Xie, Peng Guo, Qiang Yu, Juan Xiao, Kangrui Zhao, Qiong Liao, Yi Wang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2023-08-01
Sarja:	Frontiers in Pharmacology
Aiheet:	ALK rearrangement EGFR mutation lung adenocarcinoma targeted therapy case report
Linkit:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1167959/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!